At first glance, Medicare’s finalized conversion factor increase for 2026 looks like good news for orthopedic practices. Higher rates should mean higher revenue.

Laboratory reimbursement is back in the spotlight and the stakes are higher than ever before.

If there’s one frustration nearly every healthcare organization shares in 2026, it’s this:

For years, patient financial engagement was treated as a collections problem. In 2026, that framing is officially outdated.

In 2026, laboratory billing teams are facing a perfect storm.

Laboratory revenue cycle management has never been simple — but in 2026, it has become structurally harder.

Medical billing and revenue cycle management are often used interchangeably, but they are not the same thing. Understanding the difference between medical billing vs revenue cycle management is critical for healthcare practices and laboratories that want to improve cash flow, reduce denials, and gain real visibility into their financial performance.

RCM steps define how healthcare organizations track, manage, and collect revenue from the moment a patient schedules an appointment through final payment. When these steps are clearly defined and well executed, organizations improve cash flow, reduce denials, and gain better visibility into financial performance. When they are not, revenue leakage, delayed payments, and administrative strain quickly follow.

Why Accounts Receivable are the Lifeline of Every Laboratory For most laboratories, the biggest financial challenge isn’t the number of tests performed; it’s the number of claims still sitting unpaid.